Ordering
Available Variants5 mg
CHA.44714-5mg
Price
€72.56
Available – Dispatch in 14 days
25 mg
CHA.44714-25mg
Price
€295.20
Available – Dispatch in 14 days
100 mg
CHA.44714-100mg
Price
€64.48
Available – Dispatch in 14 days
500 mg
CHA.44714-500mg
Price
€247.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.44714-5mg | €72.56 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.44714-25mg | €295.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.44714-100mg | €64.48 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
500 mg | CHA.44714-500mg | €247.20 |
≥95%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C15H16N4O4 · xHCl |
|---|---|
| CAS Number | 2305369-00-8 |
| Molecular Weight | 316.31 (free base basis) |
| UNSPSC Code | 12352101 |
| NACRES | NA.21 |
| MDL number | MFCD31730839 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Pomalidomide-C2-NH2 hydrochloride, with a CAS number of 419547-11-8, is a derivative of the immunomodulatory drug pomalidomide. This compound has been investigated for its potential therapeutic applications, particularly in the treatment of certain types of cancer and inflammatory disorders. Pomalidomide-C2-NH2 hydrochloride exhibits immunomodulatory, antiangiogenic, and antineoplastic properties, which contribute to its ability to inhibit tumor growth and induce apoptosis in cancer cells. The mechanism of action of this compound involves the modulation of various cellular pathways, including the regulation of cytokine production and the inhibition of cell proliferation. Further research is needed to fully elucidate the pharmacological properties and potential clinical uses of pomalidomide-C2-NH2 hydrochloride, but its unique profile suggests that it may have value as a therapeutic agent in the treatment of various diseases. Its chemical structure and properties make it an interesting candidate for further study.
